2025

article thumbnail

Q&A: Pharmacists Play Key Role in Retinal Therapy Support | Asembia 2025

Drug Topics

Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth discusses how pharmacists can reduce patient burden.

415
415
article thumbnail

Five Key Skills for Pharmacy Residents

IDStewardship

In this article, five key skills for pharmacy residents are identified and discussed. Authored by:Asma Alamri, Pharm.D. &Huda Almalki, Pharm.D. Post-Graduate Year-1Pharmacy Residents, Taif Health Cluster, Saudi Arabia Mentored by: Sameer Alzaidi, Pharm.D., BCPS, BCIDP, AAHIVP System-Wide Post-Graduate Year-1Pharmacy Residency Program Director, Taif Health Cluster, Saudi Arabia UNDER CONSTRUCTION Article Posted January 2024 According to the American College of Clinical Pharmacy (ACCP a reside

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change

PhRMA

Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients. Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.

article thumbnail

CDC division responsible for asthma control and lead poisoning prevention effectively eliminated

STAT

After Hurricane Ian, as Floridians returned home to sodden furniture and moldy piles of debris, many with asthma could feel their chests tightening. To figure out what was safe, some sent their concerns directly to the U.S. Centers for Disease Control and Prevention.  But on Tuesday — days before floods ravaged Nashville, potentially prompting similar queries — the people who would normally answer such asthma questions stopped working.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs

The FDA Law Blog

By Kurt R. Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As the dust begins to settle and we all assess what this means for the future of FDA and the public health, generally, this blogger wanted to call out one particular division in the Office of Generic Drugs (OGD), funded by user fees under the Generic Drug User Fee Amendments (GDUFA), that was eradicated and what t

FDA 144
article thumbnail

Genetic breakthroughs could point pharma to a long COVID drug

PharmaVoice

The discoveries also hold potential benefits for patients with other conditions, such as chronic fatigue syndrome.

342
342

More Trending

article thumbnail

Treating OUD With Buprenorphine Improves Pregnancy Outcomes

Drug Topics

Among patients treated with buprenorphine, 25.4% experienced adverse pregnancy outcomes, compared to 30.8% in the untreated group.

315
315
article thumbnail

E-Prescribing Can Help Improve Prescriber, Pharmacist Collaboration

Drug Topics

The use of electronic prescribing can also bridge the gap in clinical history, which can help pharmacists be aware of adverse drug reactions and medication interactions.

315
315
article thumbnail

Mark Cuban Cost Plus Drugs Provides More Cost Savings for Dermatology Prescription

Drug Topics

Researchers conducted an observational cost analysis of dermatology drug savings between GoodRx and Mark Cuban Cost Plus Drug Company.

684
684
article thumbnail

FDA Grants Fast Track Designation for Potential Bird Flu Vaccine

Drug Topics

The designation addresses the unmet need for prevention of H5N1, which remains a global health risk, and a phase 1 trial of the vaccine was initiated in November 2024.

Vaccines 691
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The 3 Types of PBM Reform Aiming to Change the Pharmaceutical Market

Drug Topics

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discusses litigious, market-based, and legislative reform for pharmacy benefit managers.

640
640
article thumbnail

Experts Warn Public to Prepare for Potential Bird Flu Pandemic

Drug Topics

Coalition for Epidemic Preparedness Innovations experts warned of the potential for bird flu to become a pandemic event if officials dont prepare quickly.

684
684
article thumbnail

Alarm Bells are Ringing: Medicare Drug Price Negotiation Program Will Fail Without Changes

Drug Topics

If CMS doesnt reconsider its mandate, which forces independent pharmacies to go deep into a hole and lose money, many of them will close.

article thumbnail

PBM Reform Delays Continue to Negatively Impact Pharmacies | AAP 2025

Drug Topics

A conversation with Douglas Hoey, CEO of the National Community Pharmacists Association, at the American Associated Pharmacies 2025 Annual Conference.

624
624
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

COVID-19 Had Worst Disease Outcomes Among Respiratory Viruses

Drug Topics

In their exploration of 2 separate respiratory virus seasons, researchers examined the severity of illness for SARS-CoV-2, influenza, and respiratory syncytial virus.

628
628
article thumbnail

Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing

Drug Topics

US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.

613
613
article thumbnail

Challenges for Pharmacies in 2025: What to Expect and How to Prepare

Drug Topics

Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field. But the coming year will bring challenges affecting patient care, the industry workforce and their business. Pharmacies must be ready to do more than weather the storm; they need deliberate strategy and sophisticated tools to thrive amidst these obstacles. This white paper will discuss the issues and solutions that should be at the top of every pharmacy professionals mind as they start the new year.

article thumbnail

A closer look at how health care consolidation drives up patient costs, creates barriers to care

PhRMA

Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c

Insurance 263
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pregnancy Could Help Reduce the Risk of Long COVID

Drug Topics

A study found that patients who acquired a SARS-CoV-2 infection during pregnancy had a lower risk of developing long COVID compared to those who were not pregnant.

577
577
article thumbnail

GLP-1 Medications Continue to Increase Market Growth | Asembia 2025

Drug Topics

Glucagon-like peptide-1 medications are the fastest-growing class of medication and will continue to be prevalent as more indications, such as sleep apnea, are added.

544
544
article thumbnail

Buprenorphine Option Did Not Improve Pain, Reduce Opioid Dosage

Drug Topics

Patients prescribed high-dose opioids were given the option to switch to buprenorphine in hopes of improving pain and reducing opioid dosage.

Dosage 593
article thumbnail

National Association of Attorneys General Urges Congress to Prohibit PBM-Owned Pharmacies

Drug Topics

On behalf of 39 state and territory attorneys general, the National Association of Attorneys General issued a letter to Congress regarding major PBMs conflicts of interest.

560
560
article thumbnail

Over 300 Pharmacy Closures Reported in the Last 3 Months

Drug Topics

A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress failure to pass PBM reform at the end of 2024.

574
574
article thumbnail

Medicare Drug Price Negotiations Expose Community Pharmacies to Financial Risk

Drug Topics

A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Acts Medicare Drug Price Negotiation Program.

article thumbnail

IRA Drug Price Negotiations to Have Far-Reaching Consequences on Health Care System | Asembia 2025

Drug Topics

The Inflation Reduction Act's drug price negotiations could lead to reimbursement complexities, potential pharmacy closures, and reduced patient access to medications, particularly specialty drugs.

501
501
article thumbnail

STIs Pose Significant Threat to Fertility, Global Women’s Health

Drug Topics

In the researchers review of data since 1990, they explored the global burden of infertility and the extent in which it is caused by either STIs or maternal sepsis.

499
499
article thumbnail

Dispensing Leadership: Finding Solutions

Drug Topics

In this episode of the podcast, Shawn and Jesse discuss how every situation has a solution and the best way to find it.

247
247
article thumbnail

Bird Flu Hospitalizes 2 More Patients as Outbreaks Increase

Drug Topics

Bird flu cases total 70 US patients as more animals are infected.

Hospitals 522
article thumbnail

ADA Updates Diabetes Treatment Guidelines to Reelect Benefits of GLP-1

Drug Topics

Further, the authors of the Standards of Care in Diabetes 2025 highlighted the benefits of continuous glucose monitoring systems and recommend initiating these as soon as possible.

498
498
article thumbnail

Drug Shortages, Affordability Remain Top Concerns in Managed Care Pharmacy

Drug Topics

Approximately, 62% of respondents stated that the number of active drug shortages could potentially increase by more than 25% within the next 5 years.

516
516
article thumbnail

Assertive Self-Expression Crucial in Community Pharmacist Deprescribing

Drug Topics

Researchers explored various types of self-expression among pharmacists and how they were associated with experience in community pharmacy-led deprescribing.

article thumbnail

The Current, Future Roles of AI within the Pharmacy Profession

Drug Topics

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

516
516
article thumbnail

Pain, Anxiety Main Predictors of Decreased Quality of Life in Long COVID

Drug Topics

A study found that of 110 patients with long COVID, over half reported decreased QOL due to pain, discomfort, anxiety, or depression.

529
529